UNSPSC 51351636: Estradiol cypionate/medroxyprogesterone acetate

Estradiol cypionate/medroxyprogesterone acetate (EC/MPA) is a form of combined injectable birth control.[2] It contains estradiol cypionate (EC), estrogen, and medroxyprogesterone acetate (MPA), a progestin.

UNSPSC 51351636 Estradiol cypionate/medroxyprogesterone acetate (Commodity) comprises pharmaceutical products that state and local governments procure primarily through health departments, county health systems, and public safety agencies for emergency medical services and community health programs. Recent solicitations show activity concentrated in emergency response contexts: Seminole County, Florida procured 1,900 units of Naloxone annually through an IFB posted June 30, 2026, with delivery due July 26, 2023; the City of Tucson Fire Department solicited basic and advanced life support pharmaceuticals and supplies through RFP 260217 posted June 24, 2026, covering 251 line items with estimated annual usage ranging from 1 to 120,000 units per item; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued an RFP on January 20, 2026, to establish contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities and Oregon, with proposals due March 26, 2026. Issuing bodies include county health departments, city fire departments, and cooperative purchasing alliances spanning multiple states. The code also captures forensic drug analysis standards; Pinellas County, Florida procured certified drug reference materials through ITQ 26-0305-ITQ posted April 23, 2026, for use in toxicology and seized drug analysis operations.

Geographic activity appears concentrated in Florida and the Southwest, with secondary activity in Minnesota's cooperative purchasing network. Tucson's procurement is noteworthy for its scale and complexity—it involves 251 line items, requires Arizona State Board of Pharmacy wholesaler licensing, mandates 95 percent fill rates and 48-hour delivery with emergency same-day capability, and integrates controlled-substance delivery directly to fire stations alongside centralized supply distribution. The contract carries federal compliance obligations (Davis-Bacon, Buy America, Section 3 labor targets) and multi-year renewal options through year five. MMCAP's RFP signals sustained demand for pharmaceutical supply through cooperative channels, with pricing weighted at 75 percent of evaluation and mandatory compliance with Drug Supply Chain Security Act standards. Seminole County's Naloxone procurement spans annual quantities with quarterly deliveries and two-year initial terms plus optional renewal, funded potentially through FEMA with associated federal compliance requirements. Most opportunities specify firm pricing for contract duration, insurance requirements (commercial general liability typically $1 million to $5 million per occurrence), and delivery timelines of 48 hours to quarterly intervals depending on product and jurisdiction.